CFMS — ConforMIS Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $17.80m
- $12.26m
- $62.05m
Annual income statement for ConforMIS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 89.8 | 77.4 | 68.8 | 99.9 | 62 |
| Cost of Revenue | |||||
| Gross Profit | 48.5 | 36.7 | 33.7 | 65.7 | 23.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 128 | 103 | 93.9 | 98.1 | 108 |
| Operating Profit | -38.7 | -25.1 | -25.1 | 1.79 | -46.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -43.3 | -28.4 | -24.3 | -2.32 | -50.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -43.4 | -28.5 | -24.3 | -2.41 | -50.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -43.4 | -28.5 | -24.3 | -2.41 | -50.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -43.4 | -28.5 | -24.3 | -2.41 | -50.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -15.9 | -11.1 | -8.47 | -0.83 | -6.99 |